Our speakers will break down the top government enforcement trends they are seeing and which ones they predict will be relevant to life sciences and healthcare companies in 2022. Our panelists will cover the pressing questions that innovative companies in the space are wondering:
- Where are we likely to see government enforcement action and scrutiny in the life sciences industry and what are key risk areas under the Anti-Kickback Statute?
- What are the hot issues in FCA litigation pertinent to life science and healthcare companies?
- What novel causes of enforcement action will we see reach beyond the traditional scope of existing regulations and target companies in the industry?
Our partners, some of whom have recently joined and have first-hand government experience, will provide thoughtful insight into these and other hotbed enforcement issues.
This webinar is part of our 2022 Life Sciences & Healthcare Innovation Program, Cooley’s 15th annual event in conjunction with the J.P. Morgan Healthcare Conference.
For more information, please email Deborah Argueta.